As the first cohort of patients are dosed in the Phase II trial, multiple new trial sites are added for the glioblastoma ...

SELLAS has announced positive data from preclinical studies identifying the ASXL1 mutation as a predictor of response to ...

JELMYTO (mitomycin) for pyelocalyceal solution treats low-grade, upper tract urothelial cancer in adult population. Credit: SewCreamStudio/Shutterstock. UroGen Pharma ...

Sequana Medical’s other lead candidate is alfapump, a device for patients with a buildup of fluid in the abdomen. Image credit: Shutterstock / Sadovnikova Olga. Following positive data reported ...

Conducted across 88 sites in seven countries, the trial included subjects from a diverse demographic. Credit: New Africa/Shutterstock. Gilead Sciences has announced the outcomes from the randomised ...

Asthma and COPD affect millions of patients worldwide. Credit: Andrew Angelov / Shutterstock. A Phase II investigator-led trial investigating AstraZeneca’s Fasenra (benralizumab) treating eosinophilic ...

Aulos Bioscience has announced the first patients have been dosed as part of a trial investigating avelumab, marketed as ...

Anocca has submitted its first clinical trial application (CTA) for conducting the Phase I/II VIDAR-1 trial to the EMA.

Real-world evidence (RWE) trials mainly involve observational data outside the traditional involvement of randomised ...

The Norse Eight trial was part of the data requested by the FDA after the agency rejected the BLA for the company’s Lytenava ...

The announcement means the company will be pulling the plug on the CardinALS trial after its ALS drug failed to halt disease ...

Lexicon Pharmaceuticals has completed the enrolment of subjects for the multicentre Phase IIb PROGRESS trial of LX9211 to ...